Alcohol-Induced Mitochondrial Dysfunction and the Hepatocyte Clock

酒精引起的线粒体功能障碍和肝细胞时钟

基本信息

项目摘要

 DESCRIPTION (provided by applicant): Alcoholic liver disease (ALD) is a major cause of morbidity and mortality from chronic alcohol consumption. Despite increased medical and scientific knowledge of ALD, the molecular events responsible for ALD remain poorly understood. Previous studies from our labs have shown that mitochondrial bioenergetic function is severely compromised in the liver following chronic alcohol consumption and is a significant causative factor for hepatocyte necrosis. However, the mechanisms responsible for mitochondrial damage remain unknown. We propose that disruption in the hepatocyte molecular circadian clock underpins chronic alcohol-induced mitochondrial dysfunction. Published studies have shown that the clock influences hepatic oxidative metabolism (β-oxidation) and that key regulators of mitochondrial biogenesis (Pgc1a) exhibit diurnal rhythms in peripheral tissues. Importantly, we have found that rhythms in Pgc1a, Pgc1b, and Pdk4 are significantly dampened in livers of alcohol-fed mice, suggesting that the ability of mitochondria to be metabolically flexible and responsive to time-of-day dependent fluctuations in energetic supply and demand is severely compromised in the chronic alcohol-exposed liver. In line with this, we observed that the transcription factor, nuclear respiratory factor 1 (Nrf1), which is essential for integration o nuclear and mitochondrial encoded gene transcription exhibits a diurnal rhythm, that is abolished by genetic disruption of the circadian clock in the liver. Moreover, we found that the activity of cytochrome c oxidase, the terminal and rate-limiting enzyme of the mitochondrial respiratory chain, displays a robust diurnal rhythm in liver mitochondria from control mice that is significantly depressed by chronic alcohol. Taken together, these new data strongly suggest that the circadian clock regulates mitochondrial function over the course of the day, and that disruption in these rhythms by chronic alcohol impairs hepatic bioenergetic function. Accordingly, our long-term goal is to test the hypothesis that chronic alcohol-mediated disruption in the liver clock is a critical mechanism underpinning hepatic mitochondrial dysfunction in the chronic alcohol consumer. To test this hypothesis we propose the following Aims. In Aim 1, we will determine whether the hepatocyte clock directly regulates mitochondrial bioenergetics and influences chronic alcohol-induced mitochondrial dysfunction in the liver. In Aim 2, we will determine whether alcohol-mediated alterations in the hepatocyte clock and impairments in liver mitochondrial bioenergetics can be treated with a drug (an ROR ligand) targeting the clock. This project will be facilitated by using a genetic mouse model in which the hepatocyte circadian clock is nonfunctional, namely the hepatocyte- specific BMAL1 knockout mouse. In summary, these innovative studies will provide new insight regarding the mechanisms by which the circadian clock regulates cellular bioenergetic homeostasis and reveal that chronic alcohol-mediated disruption to the clock contributes to mitochondrial dysfunction in the liver. Moreover, this work will likely lay a foundation for future pharmacological studies targeting the clock in treating ALD patients.
 描述(由申请人提供):酒精性肝病(ALD)是慢性饮酒导致发病和死亡的主要原因。尽管对ALD的医学和科学知识有所增加,但对ALD的分子事件仍然知之甚少。我们实验室以前的研究表明,慢性饮酒后肝脏线粒体生物能量功能严重受损,是肝细胞坏死的重要致病因素。然而,负责线粒体损伤的机制仍然未知。我们认为肝细胞分子生物钟的破坏是慢性酒精诱导的线粒体功能障碍的基础。已发表的研究表明,生物钟影响肝脏氧化代谢(β-氧化),线粒体生物合成的关键调节因子(Pgc 1a)在外周组织中表现出昼夜节律。重要的是,我们发现Pgc 1a,Pgc 1b和Pdk 4的节律在酒精喂养的小鼠肝脏中显着减弱,这表明线粒体代谢灵活性和对能量供应和需求的时间依赖性波动的反应能力在慢性酒精暴露的肝脏中严重受损。与此一致,我们观察到,转录因子,核呼吸因子1(Nrf 1),这是必不可少的整合核和线粒体编码的基因转录表现出昼夜节律,这是废除了遗传破坏的昼夜节律在肝脏中。此外,我们发现,细胞色素c氧化酶的活性,线粒体呼吸链的末端和限速酶,显示了一个强大的昼夜节律,在对照小鼠的肝线粒体, 长期酗酒导致抑郁总之,这些新数据强烈表明,昼夜节律钟在一天中调节线粒体功能,而慢性酒精对这些节律的破坏会损害肝脏的生物能量功能。因此,我们的长期目标是检验这一假设,即慢性酒精介导的肝时钟中断是慢性酒精消费者肝线粒体功能障碍的关键机制。为了验证这一假设,我们提出了以下目标。在目标1中,我们将确定肝细胞时钟是否直接调节线粒体生物能量学并影响肝脏中慢性酒精诱导的线粒体功能障碍。在目标2中,我们将确定酒精介导的肝细胞时钟改变和肝线粒体生物能量学损伤是否可以用靶向时钟的药物(ROR配体)治疗。该项目将通过使用肝细胞生物钟无功能的遗传小鼠模型,即肝细胞特异性BMAL 1敲除小鼠来促进。总之,这些创新的研究将提供关于生物钟调节细胞生物能量稳态的机制的新见解,并揭示慢性酒精介导的生物钟破坏导致肝脏线粒体功能障碍。此外,这项工作可能会为未来针对治疗ALD患者的时钟的药理学研究奠定基础。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cellular Abnormalities and Emerging Biomarkers in Alcohol-Associated Liver Disease.
酒精相关肝病中的细胞异常和新兴生物标志物。
  • DOI:
    10.3727/105221618x15325235888914
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Singal,AshwaniK;Bailey,ShannonM
  • 通讯作者:
    Bailey,ShannonM
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHANNON MARIE BAILEY其他文献

SHANNON MARIE BAILEY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHANNON MARIE BAILEY', 18)}}的其他基金

Circadian and mitochondrial dysfunction in alcohol-related liver disease
酒精相关性肝病中的昼夜节律和线粒体功能障碍
  • 批准号:
    10667861
  • 财政年份:
    2023
  • 资助金额:
    $ 17.46万
  • 项目类别:
Circadian rhythms and alcohol in the BMAL1 knockout rat
BMAL1 敲除大鼠的昼夜节律和酒精
  • 批准号:
    10451307
  • 财政年份:
    2022
  • 资助金额:
    $ 17.46万
  • 项目类别:
Circadian rhythms and alcohol in the BMAL1 knockout rat
BMAL1 敲除大鼠的昼夜节律和酒精
  • 批准号:
    10707005
  • 财政年份:
    2022
  • 资助金额:
    $ 17.46万
  • 项目类别:
Molecular circadian clocks and alcohol-induced liver injury
分子生物钟和酒精性肝损伤
  • 批准号:
    9759734
  • 财政年份:
    2018
  • 资助金额:
    $ 17.46万
  • 项目类别:
Hepatocyte Clock and Alcoholic Fatty Liver Injury
肝细胞时钟与酒精性脂肪肝损伤
  • 批准号:
    8144478
  • 财政年份:
    2010
  • 资助金额:
    $ 17.46万
  • 项目类别:
Hepatocyte Clock and Alcoholic Fatty Liver Injury
肝细胞时钟与酒精性脂肪肝损伤
  • 批准号:
    8065283
  • 财政年份:
    2010
  • 资助金额:
    $ 17.46万
  • 项目类别:
Alcoholic Liver Dysfunction Potentiation by Hyperlipidemia and Cigarette Smoke
高脂血症和吸烟加剧酒精性肝功能障碍
  • 批准号:
    8316433
  • 财政年份:
    2009
  • 资助金额:
    $ 17.46万
  • 项目类别:
Alcoholic Liver Dysfunction Potentiation by Hyperlipidemia and Cigarette Smoke
高脂血症和吸烟加剧酒精性肝功能障碍
  • 批准号:
    7932863
  • 财政年份:
    2009
  • 资助金额:
    $ 17.46万
  • 项目类别:
Alcoholic Liver Dysfunction Potentiation by Hyperlipidemia and Cigarette Smoke
高脂血症和吸烟加剧酒精性肝功能障碍
  • 批准号:
    7798912
  • 财政年份:
    2009
  • 资助金额:
    $ 17.46万
  • 项目类别:
Alcoholic Liver Dysfunction Potentiation by Hyperlipidemia and Cigarette Smoke
高脂血症和吸烟加剧酒精性肝功能障碍
  • 批准号:
    8127680
  • 财政年份:
    2009
  • 资助金额:
    $ 17.46万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 17.46万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 17.46万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.46万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.46万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 17.46万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.46万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 17.46万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 17.46万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 17.46万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.46万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了